Overview

Gastrectomy Plus Chemotherapy Versus Chemotherapy Alone for Advanced Gastric Cancer With a Single Non-curable Factor

Status:
Enrolling by invitation

Trial end date:
2022-01-01

Target enrollment:

Participant gender:

Summary

Investigators assessed the effectiveness of conversional gastrectomy compared with chemotherapy alone following docetaxel, oxalipaltin and S1 therapy for advanced gastric cancer with a single non-curable factor.

Phase:

Phase 3

Details

Lead Sponsor:

Shanghai Zhongshan Hospital

Treatments:

Docetaxel
Oxaliplatin
Tegafur